Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases

American Journal of Clinical Pathology

Volumn 131, Issue 2, 2009, Pages 228-242

  Esposito, Nicole Nicosia ^a,b   Dabbs, David J ^a   Bhargava, Rohit ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Basement membrane; Carcinoma; Collagen, type iv; Encapsulated papillary carcinoma; Papillary carcinoma

Indexed keywords

COLLAGEN TYPE 4; TUMOR MARKER;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MASTECTOMY; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; BREAST TUMOR; CHEMISTRY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; LYMPH NODE; MIDDLE AGED; MULTIPLE CANCER; PAGET NIPPLE DISEASE; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; COLLAGEN TYPE IV; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 58849164465     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP8A2UVLCYGTPU     Document Type: Article

References (24)

1. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52:20-29.
2. Fayanju OM, Ritter J, Gillanders WE, et al. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg. 2007;194:497-500.
3. Mulligan AM, O'Malley FP. Papillary lesions of the breast: a review. Adv Anat Pathol. 2007;14:108-119.
4. Collins LC, Carlo VP, Hwang H, et al. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30:1002-1007.
5. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol. 2005;123:36-44.
6. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol. 2007;15:143-147.
7. Dabbs DJ. Diagnostic Immunohistochemistry. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2006.
8. Bosman FT, Havenith MG, Visser R, et al. Basement membranes in neoplasia. Prog Histochem Cytochem. 1992;24:1-92.
9. Barsky SH, Siegal GP, Jannotta F, et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest. 1983;49:140-147.
10. Bosman FT. The borderline: basement membranes and the transition from premalignant to malignant neoplasia. Microsc Res Tech. 1994;28:216-225.
11. Siegal GP, Barsky SH, Terranova VP, et al. Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components: an immunoperoxidase study. Invasion Metastasis. 1981;1:54-70.
12. Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast: after mastectomy, radiotherapy or excisional biopsy alone. Cancer. 1983;52:14-19.
13. Harris KP, Faliakou EC, Exon DJ, et al. Treatment and outcome of intracystic papillary carcinoma of the breast. Br J Surg. 1999;86:1274.
14. Leal C, Costa I, Fonseca D, et al. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum Pathol. 1998;29:1097-1104.
15. Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol. 1994;25:802-809.
16. Kallioinen M, Autio-Harmainen H, Dammert K, et al. Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies. J Invest Dermatol. 1984;82:248-251.
17. Gusterson BA, Warburton MJ, Mitchell D, et al. Invading squamous cell carcinoma can retain a basal lamina: an immunohistochemical study using a monoclonal antibody to type IV collagen. Lab Invest. 1984;51:82-87.
18. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin, part II: epitheliosis and ductal carcinoma in situ. Virchows Arch A Pathol Anat Histopathol. 1992;421:323-330.
19. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin, part I: normal breast and benign proliferative lesions. Virchows Arch A Pathol Anat Histopathol. 1992;421:315-322.
20. Leong FJ, Leong AS, Brady M, et al. Basal lamina visualization using color image processing and pattern recognition. Appl Immunohistochem Mol Morphol. 2005;13:273-276.
21. Raymond WA, Leong AS. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology. 1991;23:291-297.
22. Rosen PP. Rosen's Breast Pathology. Philadelphia, PA: Lippincott-Raven; 1997.
23. Wilkie C, White L, Dupont E, et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg. 2005;190:563-566.
24. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2001;67:513-521.